Dnca Finance »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Dnca Finance

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Dnca Finance from 13F filings

Historical chart of Dnca Finance investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Dnca Finance consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Dnca Finance

Quarter filed Position value Share count Share price at filing
2024-09-30 $477k 400k 1.19

More positions owned by Dnca Finance

Flutter Entmt SHS (FLUT)
Crh Plc O Ord (CRH)
Microsoft Corporation (MSFT)
Visa Com Cl A (V)
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Ferrari Nv Ord (RACE)
Linde SHS (LIN)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Deere & Company (DE)
Alphabet Cap Stk Cl A (GOOGL)
Trane Technologies SHS (TT)
Spotify Technology S A SHS (SPOT)
Broadcom (AVGO)
Amazon (AMZN)

View all positions for Dnca Finance

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&G
Citadel Advisors
MacKay Shields
Lazard Asset Management
Calamos Advisors
Polar Securities
BlackRock
Wolverine Asset Management
Ing Investment Management
Wells Fargo & Company
CNH Partners
State Street Corporation
BlackRock
Absolute Investment Advisers
Glazer Capital

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1